Authors:
Ballany, J
Caddy, B
Cole, M
Finnon, Y
Aalberg, L
Janhunen, K
Sippola, E
Andersson, K
Bertler, C
Dahlen, J
Kopp, I
Dujourdy, L
Lock, E
Margot, P
Huizer, H
Poortman, A
Kaa, E
Lopes, A
Citation: J. Ballany et al., Development of a harmonised pan-European method for the profiling of amphetamines, SCI JUSTICE, 41(3), 2001, pp. 193-196
Authors:
Kopp, I
Bartsch, D
Wild, A
Schilling, T
Nies, C
Bergenfelz, A
Reider, H
Simon, B
Rothmund, M
Citation: I. Kopp et al., Predictive genetic screening and clinical findings in multiple endocrine neoplasia type I families, WORLD J SUR, 25(5), 2001, pp. 610-616
Authors:
Langer, P
Wild, A
Celik, I
Kopp, I
Bergenfelz, A
Bartsch, DK
Citation: P. Langer et al., Prospective controlled trial of a standardized meal stimulation test in the detection of pancreaticoduodenal endocrine tumours in patients with multiple endocrine neoplasia type 1, BR J SURG, 88(10), 2001, pp. 1403-1407
Citation: I. Kopp et al., Management of patients with rectal carcinoma. Classical outcomes and implementation of the quality of life concept into medical care, ZBL CHIR, 125(12), 2000, pp. 940-946
Authors:
Saar, B
Heverhagen, JT
Obst, T
Berthold, LD
Kopp, I
Klose, KJ
Wagner, HJ
Citation: B. Saar et al., Magnetic resonance colonography and virtual magnetic resonance colonoscopywith the 1.0-T system - A feasibility study, INV RADIOL, 35(9), 2000, pp. 521-526
Authors:
Bartsch, D
Kopp, I
Bergenfelz, A
Rieder, H
Deiss, Y
Munch, K
Rothmund, M
Simon, B
Citation: D. Bartsch et al., Germ-line mutations in the gene for multiple endocrine neoplasia type 1 (MEN 1): basis for predictive genetic screening and clinical management of MEN 1 families, DEUT MED WO, 123(51-52), 1998, pp. 1535-1540